Shows
Surfing the MASH TsunamiS5 - E6.3 - Staging and screening patients for Rezdiffra using NITsThis conversation focuses on the necessity of using NITs to screen and identify Rezdiffra patients, while at the same time acknowledging the shortcomings of current tests. Panelists suggest some different NIT testing strategies while commenting on upsides and potential challenges for each MASH NIT.Laurent Castera joins the conversation at the beginning, which is helpful given his extensive research and knowledge of the surrounding communities. Laurent points out that distinguishing F3 patients from F4 will be a difficult challenge to solve, in part because we used categorical scores for fibrosis instead of recognizing that it is, in...
2024-03-1815 minSurfing the MASH TsunamiS2-E32 - Leaders Provide Perspectives on #ILC2021Incoming EASL Secretary General Prof. Thomas Berg, Global Liver Institute President and CEO Donna Cryer and Genfit Head of Global Diagnostics Suneil Hosmane share their unique perspectives on Digital ILC 2021 with Roger Green.In our lead-in episode for #ILC2021, Roger Green conducts interviews with three leaders, each with a unique perspective on what they value about this week's Congress. Incoming EASL Secretary General Prof. Thomas Berg discusses his view on the various ways the Congress will enrich knowledge and interaction in the global Fatty Liver community. Global Liver Institute President and CEO Donna Cryer...
2021-06-2558 minSurfing the MASH TsunamiS2-E24 - Fourth Global NASH Congress -- Wrapping UpThe SurfingNASH coverage team from the Fourth Global NASH Congress convenes one more time to consider key takeaways from the Congress. Manal Abdelbalek, Naim Alkhouri, Ian Rowe, Suneil Hosmane, Louise Campbell and Roger Green all share high points, opportunities and lingering questions.On April 28 and 29, 2021, over 175 Fatty Liver stakeholders from across the globe convened virtually for the Fourth Global NASH Congress, and Surfing the NASH Tsunami was there to hear each of 43 speakers and share highlights with our listeners. Now that the Congress has ended and everyone has had time to reflect, the coverage team...
2021-05-0652 minSurfing the MASH TsunamiS2-E23.1 - From the Fourth Global NASH Congress -- Diagnosing DiagnosticsThe SurfingNASH Team has curated over three hours of recordings from the Fourth Global NASH Congress to highlight pieces that discuss the current and future states of diagnostics in Fatty Liver disease. You will hear Manal Abdelmalek, Naim Alkhouri, Suneil Hosmane, Ian Rowe, Jörn Schattenberg, Louise Campbell and Roger Green sharing opinions and debating issues.Discussions about diagnostics ran through SurfingNASH's entire coverage of the Fourth Global NASH Congress. Listen here for some of the diagnostics highlights. The group discusses exciting new precision diagnostics, urine and breath-based biopsies, realistic expectations for diagnostics in market t...
2021-05-0334 minSurfing the MASH TsunamiS2-E23 - Wrapping up Day Two of the Fourth Global NASH Congress -- Drugs, lifestyles and Health policyIan Rowe and GenFit Global Diagnostics Leader Suneil Hosmane join Louise and Roger as they keep discussing Day Two of the 4th Global NASH Congress.On April 29, over 175 NASH stakeholders from across the globe met virtually to hear 20 presentations from leaders in academia and industry. SurfingNASH selected 9 presentations to discuss in a session recorded right after the conference concluded. When the five panelists got together, the discussion extended to 90 minutes...too long for a single episode.Episode 23 features Suneil Hosmane discussing lifestyle and exercise, Ian Rowe discuss public policy in the US Veterans...
2021-05-0144 minSurfing the MASH TsunamiS2-E22 - Day Two at the 4th Global NASH Congress -- many New Drugs and Non-Pharmacologic InterventionsNaim Alkhouri, Ian Rowe and GenFit Global Diagnostics Leader Suneil Hosmane join Louise Campbell and Roger Green to review presentations from Day Two at the 4th Global NASH Congress.On April 29, over 175 NASH stakeholders from across the globe met virtually to hear 20 presentations from leaders in academia and industry. SurfingNASH selected 9 presentations to discuss in a session recorded right after the conference concluded. When the five panelists got together, the discussion extended to 90 minutes...too long for a single episode.Episode 22 features Naim Alkhouri and Louise Campbell discussing featured presentations on genomics, transcriptomics a...
2021-04-3042 minSurfing the MASH TsunamiS2-E21 - Day One At The 4th Global NASH Congress -- Diagnostics, Drugs And Regulatory IssuesManal Abdelmalek, Jörn Schattenberg and GenFit Global Diagnostics Leader Suneil Hosmane join the Surfers to review presentations from Day One at the 4th Global NASH Congress.On April 28, over 175 NASH stakeholders from across the globe will meet virtually to hear 23 presentations from leaders in academia and industry. SurfingNASH has selected 11 presentations to discuss in a session we will record right after the conference concludes. The speakers and their broad topic areas are:Manal Abdelmalek -- innovative non-invasive non-device diagnosticsJörn Schattenberg -- Developmental drugs that address fructose metabolismSuneil Hosmane...
2021-04-291h 01Surfing the MASH TsunamiS2-E19.3 - Pharmacotherapy Themes At The 4th Global NASH CongressJörn Schattenberg and GenFit Global Diagnostics Leader Suneil Hosmane join the Surfers to review pharmacotherapy themes to be covered at the 4th Global NASH Congress.Keynote Speaker Suneil Hosmane joins Louise Campbell and Roger Green to form the coverage team for the 4th Global NASH Congress. In this conversation, Jörn Schattenberg joins them to review drug-related topics covered at the Congress. This conversation discusses issues ranging from modes of action that attack fructose metabolism to the importance of hearing regulators at meetings like this one. Listen to get a feel for what commercial, fi...
2021-04-1812 minSurfing the MASH TsunamiS2-E19.2 - Patient-Centric Themes At The 4th Global NASH CongressJörn Schattenberg and GenFit Global Diagnostics Leader Suneil Hosmane join the Surfers to review holistic and patient-centric issues to be covered at the 4th Global NASH Congress.Keynote Speaker Suneil Hosmane joins Louise Campbell and Roger Green to form the coverage team for the 4th Global NASH Congress. In this conversation, Jörn Schattenberg joins them to review patient-centric topics covered at the Congress. This conversation discusses the increasing imoportance of phenotyping in diagnosing and prescribing for individual patients after drugs are available. Listen to get a feel for what commercial, financial and R & D...
2021-04-1716 minSurfing the MASH TsunamiS2-E19.1 - Non-Invasive Testing Themes at the 4th Global NASH CongressJörn Schattenberg and GenFit Global Diagnostics Leader Suneil Hosmane join the Surfers to review non-invasive testing themes to be covered at the 4th Global NASH Congress.Keynote Speaker Suneil Hosmane joins Louise Campbell and Roger Green to form the coverage team for the 4th Global NASH Congress. In this conversation, Jörn Schattenberg joins them to review non-invasive testing topics covered at the Congress. This conversation discusses advances in technology and the need for non-invasive tests that provide stronger positive predictive value. Listen to get a feel for what commercial, financial and R & D ac...
2021-04-1713 minSurfing the MASH TsunamiS2-E19 - Previewing the 4th Global NASH congressJörn Schattenberg and GenFit Global Diagnostics Leader Suneil Hosmane join the Surfers to survey the agenda for the 4th Global NASH Congress.The 4th Global NASH Congress has presentations of interest on a broad array of topics. Congress Keynote Speaker Suneil Hosmane joins Louise Campbell and Roger Green to form the coverage team for this event. Along with Jörn Schattenberg, they review the topics of interest at the Congress and highlight some papers and topics that SurfingNASH will cover in its end-of-day episodes on April 28 and 29. Listen to get a feel for what ma...
2021-04-1547 min
Dialogues on AI Digital PathologyEpisode 3 with Dr. Suneil Hosmane [Full Podcast]Listen to our guest, Dr. Suneil Hosmane (Executive Vice President and Global Head of Diagnostics at GENFIT), as he speaks about the role of AI digital pathology, the latest NIS4 blood-based diagnostic test by Genfit and how AI digital pathology can work with non-invasive technologies (NITs) to enhance drug development efforts in NASH clinical trials today that could ultimately transform the NASH clinical care pathway.
2020-11-0335 min
Dialogues on AI Digital Pathology[Official Trailer] Episode 3 with Dr. Suneil HosmaneEpisode 3 of Dialogues on AI Digital Pathology is coming up soon! Here's a sound bite from our guest, Dr. Suneil Hosmane, Executive Vice President and Global Head of Diagnostics at GENFIT, who will share his views on how AI digital pathology can work with non-invasive technologies (NITs) to enhance drug development efforts and benefit patient outcomes. Watch out for our updates next week when Episode 3 goes Live!
2020-10-2802 min